FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

412088006: Amphotericin B liposome (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2467540018 Amphotericin B liposome (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
2473690011 Amphotericin B liposome en Synonym Active Only initial character case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amphotericin B liposome Is a Amphotericin B false Inferred relationship Existential restriction modifier
Amphotericin B liposome Is a Liposomal agent true Inferred relationship Existential restriction modifier
Amphotericin B liposome Is a Amphotericin true Inferred relationship Existential restriction modifier
Amphotericin B liposome Is modification of Amphotericin B true Inferred relationship Existential restriction modifier
Amphotericin B liposome Has disposition Antifungal true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Amphotericin (lipid formulation) 50mg powder for infusion solution vial Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Product containing amphotericin B liposome Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin (lipid formulation) 100mg powder for infusion solution vial Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin (lipid formulation) 5mg/mL suspension for injection 10mL vial Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Product containing amphotericin B liposome in parenteral dosage form Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin B phospholipid complex Is a False Amphotericin B liposome Inferred relationship Existential restriction modifier
Product containing only amphotericin B liposome (medicinal product) Has active ingredient True Amphotericin B liposome Inferred relationship Existential restriction modifier 1
Product containing only amphotericin B liposome in parenteral dose form (medicinal product form) Has active ingredient True Amphotericin B liposome Inferred relationship Existential restriction modifier 1
Amphotericin B cholesteryl sulfate complex Is modification of True Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin B phospholipid complex Is modification of True Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin B lipid complex Is modification of True Amphotericin B liposome Inferred relationship Existential restriction modifier
Product containing precisely amphotericin B liposome 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Amphotericin B liposome Inferred relationship Existential restriction modifier 1
Product containing precisely amphotericin B liposome 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Amphotericin B liposome Inferred relationship Existential restriction modifier 1
Product containing precisely amphotericin B liposome 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Amphotericin B liposome Inferred relationship Existential restriction modifier 1
Product containing precisely amphotericin B liposome 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Amphotericin B liposome Inferred relationship Existential restriction modifier 1
Amphotericin B liposomal 50mg powder for dispersion for infusion vials Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin 5mg/mL infusion concentrate 20mL vial Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Abelcet 100mg/20ml suspension for injection vials (Medeus Pharma) Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Abelcet 50mg/10ml suspension for injection vials (Zeneus Pharma) Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin 100mg/20ml suspension for injection vials 10 vial Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Abelcet 100mg/20ml suspension for injection vials (Medeus Pharma) 10 vial Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Abelcet 50mg/10ml suspension for injection vials (Zeneus Pharma) 10 vial 10 x 10ml vials Has active ingredient False Amphotericin B liposome Inferred relationship Existential restriction modifier
Amphotericin phospholipid complex Is a False Amphotericin B liposome Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start